ondansetron has been researched along with Leiomyosarcoma, Epithelioid in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy and safety of ondansetron has led to the widespread use of this medication in the treatment of nausea and vomiting caused by cancer chemotherapy and radiation therapy." | 3.69 | Anaphylactoid reactions associated with ondansetron. ( Kossey, JL; Kwok, KK, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kossey, JL | 1 |
| Kwok, KK | 1 |
1 other study available for ondansetron and Leiomyosarcoma, Epithelioid
| Article | Year |
|---|---|
Anaphylactoid reactions associated with ondansetron.
Topics: Adult; Anaphylaxis; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cis | 1994 |